18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
Fiche publication
Date publication
janvier 2018
Journal
PloS one
Auteurs
Membres identifiés du Cancéropôle Est :
Pr OLIVIER Pierre, Pr COCHET Alexandre
Tous les auteurs :
Gillebert Q, Huchet V, Rousseau C, Cochet A, Olivier P, Courbon F, Gontier E, Nataf V, Balogova S, Talbot JN,
Lien Pubmed
Résumé
To prospectively evaluate the clinical impact and the diagnostic performance of FCH-PET/CT in patients with occult biochemical recurrence of prostate cancer (PCa).
Mots clés
Aged, Aged, 80 and over, Choline, administration & dosage, Fluorine Radioisotopes, administration & dosage, Humans, Male, Middle Aged, Multimodal Imaging, Neoplasm Recurrence, Local, Positron-Emission Tomography, Prospective Studies, Prostatic Neoplasms, diagnostic imaging, Tomography, X-Ray Computed
Référence
PLoS ONE. 2018 ;13(2):e0191487